19-48965347-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_000146.4(FTL):c.-161C>T variant causes a 5 prime UTR change. The variant allele was found at a frequency of 0.00000189 in 528,044 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000019 ( 0 hom. )
Consequence
FTL
NM_000146.4 5_prime_UTR
NM_000146.4 5_prime_UTR
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 5.78
Genes affected
FTL (HGNC:3999): (ferritin light chain) This gene encodes the light subunit of the ferritin protein. Ferritin is the major intracellular iron storage protein in prokaryotes and eukaryotes. It is composed of 24 subunits of the heavy and light ferritin chains. Variation in ferritin subunit composition may affect the rates of iron uptake and release in different tissues. A major function of ferritin is the storage of iron in a soluble and nontoxic state. Defects in this light chain ferritin gene are associated with several neurodegenerative diseases and hyperferritinemia-cataract syndrome. This gene has multiple pseudogenes. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-48965347-C-T is Pathogenic according to our data. Variant chr19-48965347-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 16480.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-48965347-C-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FTL | NM_000146.4 | c.-161C>T | 5_prime_UTR_variant | 1/4 | ENST00000331825.11 | NP_000137.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FTL | ENST00000331825.11 | c.-161C>T | 5_prime_UTR_variant | 1/4 | 1 | NM_000146.4 | ENSP00000366525 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.00000189 AC: 1AN: 528044Hom.: 0 Cov.: 4 AF XY: 0.00000350 AC XY: 1AN XY: 285550
GnomAD4 exome
AF:
AC:
1
AN:
528044
Hom.:
Cov.:
4
AF XY:
AC XY:
1
AN XY:
285550
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hereditary hyperferritinemia with congenital cataracts Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 19, 2013 | - - |
Likely pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | May 02, 2023 | The heterozygous c.-161C>T variant in FTL was identified by our study in one individual with hyperferritinemia. The c.-161C>T variant in FTL has been previously reported in three individuals with hereditary hyperferritinemia with congenital cataracts (PMID: 10366790, PMID: 9414313, PMID: 10366804). This variant was found to be de novo in one individual with confirmed paternity and maternity (PMID: 10366804). This variant was absent from large population studies. The number of reported affected individuals with this variant is slightly greater than expected compared to non-affected individuals with this variant. This variant has also been reported in ClinVar (Variation ID: 16480) and has been interpreted as pathogenic by Invitae and OMIM. In vitro functional studies provide some evidence that the c.-161C>T variant may impact protein function (PMID: 8233801). However, these types of assays may not accurately represent biological function. Multiple variants in the same region as c.-161C>T variant have been reported in association with disease in the literature and the c.-161C>T variant is located in the iron-responsive element (IRE) domain of FTL, which is involved in regulating L-ferritin expression, suggesting suggesting that this variant is in a hot spot and key functional domain and slightly supports pathogenicity (PMID: 19800271, 7493028, 23421845, 10383191, 22881709, 9226182). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal dominant hereditary hyperferritinemia with congenital cataracts. ACMG/AMP Criteria applied: PS2, PS3_Supporting, PS4_Supporting, PM1_Supporting, PM2_Supporting (Richards 2015). - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Clinical Genetics Laboratory, Skane University Hospital Lund | May 27, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | FTL: PS2, PM2, PS4:Moderate, PP4, PS3:Supporting - |
Hereditary hyperferritinemia with congenital cataracts;C1853578:Neuroferritinopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 20, 2023 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this variant affects FTL function (PMID: 8233801). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 16480). This variant is also known as +39C>U, +39C>T. This variant has been observed in individual(s) with FTL-related conditions (PMID: 9414313, 10366790, 10366804; Invitae). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This variant occurs in a non-coding region of the FTL gene. It does not change the encoded amino acid sequence of the FTL protein. - |
Hereditary hyperferritinemia with congenital cataracts;C1853578:Neuroferritinopathy;C3810090:L-ferritin deficiency Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 05, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at